Clinical data | |
---|---|
Trade names | Aczone |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682128 |
Pregnancy category |
|
Routes of administration |
Oral, Topical |
ATC code | D10AX05 (WHO) J04BA02 (WHO) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 70 to 80% |
Protein binding | 70 to 90% |
Metabolism | Hepatic (mostly CYP2E1-mediated) |
Biological half-life | 20 to 30 hours |
Excretion | Renal |
Identifiers | |
|
|
CAS Number | 80-08-0 |
PubChem (CID) | 2955 |
DrugBank | DB00250 |
ChemSpider | 2849 |
UNII | 8W5C518302 |
KEGG | D00592 |
ChEBI | CHEBI:4325 |
ChEMBL | CHEMBL1043 |
ECHA InfoCard | 100.001.136 |
Chemical and physical data | |
Formula | C12H12N2O2S |
Molar mass | 248.302 g/mol |
3D model (Jmol) | Interactive image |
Melting point | 175 to 176 °C (347 to 349 °F) |
|
|
|
|
Dapsone, also known as diaminodiphenyl sulfone (DDS), is an antibiotic commonly used in combination with rifampicin and clofazimine for the treatment of leprosy. It is a second-line medication for the treatment and prevention of pneumocystis pneumonia and for the prevention of toxoplasmosis in those who have poor immune function. Additionally, it has been used for acne, dermatitis herpetiformis, and various other skin conditions. Dapsone is available both topically and by mouth.
Severe side effects may include: a decrease in blood cells, red blood cell breakdown especially in those with glucose-6-phosphate dehydrogenase deficiency (G-6-PD), or hypersensitivity. Common side effects include nausea and loss of appetite. Other side effects include liver inflammation and a number of types of skin rashes. While it is not entirely clear the safety of use during pregnancy some physicians recommend that it be continued in those with leprosy. It is of the sulfone class.
Dapsone was first studied as an antibiotic in 1937. Its use for leprosy began in 1945. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The oral form is available as a generic drug and not very expensive.
Dapsone is commonly used in combination with rifampicin and clofazimine for the treatment of leprosy. It is also used to both treat and prevent pneumocystis pneumonia (PCP). It is also used for toxoplasmosis in people unable to tolerate trimethoprim with sulfamethoxazole.